These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28757050)

  • 21. Effect of topiramate following recurrent and prolonged seizures during early development.
    Cha BH; Silveira DC; Liu X; Hu Y; Holmes GL
    Epilepsy Res; 2002 Oct; 51(3):217-32. PubMed ID: 12399072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
    Millan MJ; Gobert A; Roux S; Porsolt R; Meneses A; Carli M; Di Cara B; Jaffard R; Rivet JM; Lestage P; Mocaer E; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2004 Oct; 311(1):190-203. PubMed ID: 15146031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
    Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
    Albrechet-Souza L; Borelli KG; Brandão ML
    J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment.
    de Bruin NMWJ; van Loevezijn A; Wicke KM; de Haan M; Venhorst J; Lange JHM; de Groote L; van der Neut MAW; Prickaerts J; Andriambeloson E; Foley AG; van Drimmelen M; van der Wetering M; Kruse CG
    Neurobiol Learn Mem; 2016 Sep; 133():100-117. PubMed ID: 27344942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats.
    Lemos JI; Resstel LB; Guimarães FS
    Behav Brain Res; 2010 Feb; 207(1):105-11. PubMed ID: 19800921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8.
    Maher MP; Wu N; Ravula S; Ameriks MK; Savall BM; Liu C; Lord B; Wyatt RM; Matta JA; Dugovic C; Yun S; Ver Donck L; Steckler T; Wickenden AD; Carruthers NI; Lovenberg TW
    J Pharmacol Exp Ther; 2016 May; 357(2):394-414. PubMed ID: 26989142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMDA and AMPA/kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus.
    de Freitas RL; Salgado-Rohner CJ; Biagioni AF; Medeiros P; Hallak JE; Crippa JA; Coimbra NC
    Cereb Cortex; 2014 Jun; 24(6):1518-28. PubMed ID: 23349224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of topiramate on cognitive function and single units from hippocampal place cells following status epilepticus.
    Shatskikh T; Zhao Q; Zhou JL; Holmes GL
    Epilepsy Behav; 2009 Jan; 14(1):40-7. PubMed ID: 18929683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
    Handa RJ; Hejna GM; Lorens SA
    Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus.
    Uniyal A; Singh R; Akhtar A; Bansal Y; Kuhad A; Sah SP
    Pharmacol Biochem Behav; 2019 Oct; 185():172763. PubMed ID: 31445955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
    J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.
    Yoshioka M; Matsumoto M; Togashi H; Saito H
    Pharmacol Biochem Behav; 1995; 51(2-3):515-9. PubMed ID: 7667378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
    McEown K; Treit D
    Horm Behav; 2011 Nov; 60(5):581-8. PubMed ID: 21889941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of topiramate on cognitive function and activity level following neonatal seizures.
    Zhao Q; Hu Y; Holmes GL
    Epilepsy Behav; 2005 Jun; 6(4):529-36. PubMed ID: 15878305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.